High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third‐generation TKI outcomes
Abstract Background Clinical detection of EGFR‐TKI resistance mechanism through tissue can be really challenging due to risks associated with the procedure. Thus, liquid biopsy, especially circulation tumor DNA (ctDNA) analysis, can be an adequate source for biomarker testing in targeted therapy. Ou...
Main Authors: | Yan Li, Fanshuang Zhang, Pei Yuan, Lei Guo, Ying Jianming, Jie He |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13418 |
Similar Items
-
Self-renewal of macrophages : Fighting Mafs for eternity
by: Geirsdottir, Laufey
Published: (2015) -
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
by: Cheng WC, et al.
Published: (2021-01-01) -
Role of the transcription factor c-Maf in regulating inflammatory immune responses
by: Hussein, Hind
Published: (2020) -
TKI Resistance for T790M Mutation
by: Hong WANG, et al.
Published: (2015-04-01) -
Characterization of the Maf family of polymorphic toxins in pathogenic Neisseria species
by: Anne Jamet, et al.
Published: (2015-03-01)